Active Substance: Lamivudine.
Overview
Welcome to Dwaey, specifically on EPIVIR 10mg/ml page.
This medicine contains an important and useful components, as it consists of
Lamivudineis available in the market in concentration
Lamivudine
Discontinue use if there is rapid increase in aminotransferase levels, progressive hepatomegaly, or metabolic or lactic acidosis of unknown origin. Discontinue use if clinical signs, symptoms or lab abnormalities suggestive of pancreatitis develop. Hepatomegaly or other risk factors for hepatic impairment. Monitor hepatic function in chronic hepatitis B patients. Exclude HIV infection prior to hepatitis B therapy. Renal impairment. Pregnancy.
HIV infection, Chronic hepatitis B
Hypersensitivity. Lactation.
>10% Cough,Diarrhea,Fatigue & malaise,Fever (peds),Headache,Musculoskeletal pain,Nausea,Nervous system neuropathy,Pancreatitis,Peripheral neuropathy,Nasal S/S,Vomiting 1-10% Abdominal cramps, abdominal pain,Anorexia &/or decr appetite,Arthralgia,Chills,Depression,Dizziness,Dyspepsia,Insomnia,Myalgia,Rash,Thrombocytopenia,Creatine phosphokinase increased Frequency Not Defined Body fat redistribution,Elevated amylase,Neutropenia,Hepatitis B exacerbation Potentially Fatal: Lactic acidosis associated with severe hepatomegaly and hepatic steatosis.
3
Lamivudine, a nucleoside analogue, is phosphorylated in the body to the active triphosphate form. In the active form, it inhibits hepatitis B virus polymerase and HIV reverse transcriptase enzymes.
Renal excretion may be inhibited by high doses of trimethoprim (co-trimoxazole). May antagonise the antiviral action of zalcitabine.
Information not available